The role of long non-coding RNAs in nasopharyngeal carcinoma: As systemic review

被引:42
作者
He, Rongzhang [1 ]
Hu, Zheng [1 ,2 ,3 ,4 ]
Wang, Qingmei [1 ,5 ]
Luo, Weihao [1 ]
Li, Jia [1 ]
Duan, Lili [1 ]
Zhu, Yuan-shan [1 ,2 ,3 ,4 ]
Luo, Di-xian [1 ,5 ]
机构
[1] Chenzhou Univ South China, Cent South Univ, Peoples Hosp 1,Natl Local Joint Engn Lab High Thr, Collaborat Res Ctr Postdoctoral Mobile Stn,Transl, Chenzhou 432000, Peoples R China
[2] Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha 410078, Hunan, Peoples R China
[3] Cent S Univ, Inst Clin Pharmacol, Changsha 410078, Hunan, Peoples R China
[4] Hunan Key Lab Pharmacogenet, Changsha 410078, Hunan, Peoples R China
[5] Univ South China, Peoples Hosp Chenzhou 1, Ctr Clin Pathol, Chenzhou 432000, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
nasopharyngeal carcinoma (NPC); lncRNAs; tumorigenesis; therapeutic targets; biomarker; HNF1A-AS1 REGULATES PROLIFERATION; X-CHROMOSOME INACTIVATION; COMPETING ENDOGENOUS RNA; BREAST-CANCER CELLS; POOR-PROGNOSIS; LOW EXPRESSION; UP-REGULATION; H19; GENE; METASTASIS; AFAP1-AS1;
D O I
10.18632/oncotarget.14211
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent development of cutting edge research found that long noncoding RNAs (lncRNAs) plays important roles in carcinogenesis and progression. In Southeast Asia and North Africa, nasopharyngeal carcinoma (NPC) is the most common aggressive squamous cell carcinoma. Nasopharyngeal carcinoma is most frequently occurring in males. However, nasopharyngeal carcinoma is caused by a combination of several factors as viral, environmental factors, and heredity. Till now, the potential pathway or mechanism of NPC is not well known. In our present review, we strongly emphasized on long noncoding RNAs (lncRNAs) and its significant role in nasopharyngeal carcinoma. It has been showed that lncRNAs regulate the development and progression of different types of cancers, including NPC. In addition, it has been found that chromatin organization, transcriptional and post-transcriptional events are regulated by lncRNAs. Our present review summarizes the roles of lncRNAs in nasopharyngeal carcinoma and provides an overview of the feasibility of lncRNAs as diagnosis, prognosis and potential treatment for NPC patients.
引用
收藏
页码:16075 / 16083
页数:9
相关论文
共 72 条
[1]  
[Anonymous], 2016, ONCOTARGET
[2]  
[Anonymous], TUMOUR BIOL
[3]  
[Anonymous], TUMOUR BIOL
[4]   Exosomes: New players in cell-cell communication [J].
Bang, Claudia ;
Thum, Thomas .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2012, 44 (11) :2060-2064
[5]   Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma [J].
Bo, Hao ;
Gong, Zhaojian ;
Zhang, Wenling ;
Li, Xiayu ;
Zeng, Yong ;
Liao, Qianjin ;
Chen, Pan ;
Shi, Lei ;
Lian, Yu ;
Jing, Yizhou ;
Tang, Ke ;
Li, Zheng ;
Zhou, Yanhong ;
Zhou, Ming ;
Xiang, Bo ;
Li, Xiaoling ;
Yang, Jianbo ;
Xiong, Wei ;
Li, Guiyuan ;
Zeng, Zhaoyang .
ONCOTARGET, 2015, 6 (24) :20404-20418
[6]   THE PRODUCT OF THE H19 GENE MAY FUNCTION AS AN RNA [J].
BRANNAN, CI ;
DEES, EC ;
INGRAM, RS ;
TILGHMAN, SM .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (01) :28-36
[7]   A GENE FROM THE REGION OF THE HUMAN X-INACTIVATION CENTER IS EXPRESSED EXCLUSIVELY FROM THE INACTIVE X-CHROMOSOME [J].
BROWN, CJ ;
BALLABIO, A ;
RUPERT, JL ;
LAFRENIERE, RG ;
GROMPE, M ;
TONLORENZI, R ;
WILLARD, HF .
NATURE, 1991, 349 (6304) :38-44
[8]   THE HUMAN XIST GENE - ANALYSIS OF A 17 KB INACTIVE X-SPECIFIC RNA THAT CONTAINS CONSERVED REPEATS AND IS HIGHLY LOCALIZED WITHIN THE NUCLEUS [J].
BROWN, CJ ;
HENDRICH, BD ;
RUPERT, JL ;
LAFRENIERE, RG ;
XING, Y ;
LAWRENCE, J ;
WILLARD, HF .
CELL, 1992, 71 (03) :527-542
[9]   XIST AND THE MAPPING OF THE X-CHROMOSOME INACTIVATION CENTER [J].
BROWN, SDM .
BIOESSAYS, 1991, 13 (11) :607-612
[10]   H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer [J].
Chen, J. S. ;
Wang, Y. F. ;
Zhang, X. Q. ;
Lv, J. M. ;
Li, Y. ;
Liu, X. X. ;
Xu, T. P. .
NEOPLASMA, 2016, 63 (02) :223-230